Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 1, 2008, Pages 42-50

  Kuwayama, Kenji ^a,b   Inoue, Hiroyuki ^a   Kanamori, Tatsuyuki ^a   Tsujikawa, Kenji ^a   Miyaguchi, Hajime ^a   Iwata, Yuko ^a   Miyauchi, Seiji ^b   Kamo, Naoki ^b   Kishi, Tohru ^a  

^a NATIONAL RESEARCH INSTITUTE OF POLICE SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Amphetamine type stimulant; Caco 2 cells; Intestinal absorption; MDMA; Transport

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CARRIER PROTEIN; CATION TRANSPORT PROTEIN; DIPHENHYDRAMINE;

ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL PH; CELL STRAIN CACO 2; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ABUSE; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; KINETICS; MICHAELIS CONSTANT; PRIORITY JOURNAL;

AMMONIUM CHLORIDE; CACO-2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; ION TRANSPORT; MODELS, BIOLOGICAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PERMEABILITY; PROTONS; REGRESSION ANALYSIS; TIME FACTORS;

EID: 38149118966     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.08.023     Document Type: Article

References (47)

1. National Police Agency of Japan. White Paper on Police (2005), National Police Agency of Japan, Tokyo 191-192
2. Makino Y., Tanaka S., Kurobane S., Nakauchi M., Terasaki T., and Ohta S. Profiling of illegal amphetamine-type stimulant tablets in Japan. J. Health Sci. 49 (2003) 129-137
3. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 165 (2001) 917-928
4. Dal Cason T.A. An evaluation of the potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homologs. J. Forensic Sci. 35 (1990) 675-697
5. Fineschi V., and Masti A. Fatal poisoning by MDMA (ecstasy) and MDEA: a case report. Int. J. Leg. Med. 108 (1996) 272-275
6. Ahmad K. Increased use of amphetamine-type stimulants threatens east Asian countries. Lancet 359 (2002) 1927
7. Wolff K., Hay A.W., Sherlock K., and Conner M. Contents of "ecstasy". Lancet 346 (1995) 1100-1101
8. Jansen K.L., and Darracot-Cankovic R. The nonmedical use of ketamine, part two: a review of problem use and dependence. J. Psychoact. Drugs 33 (2001) 151-158
9. Bertelsen K.M., Greenblatt D.J., and von Moltke L.L. Apparent active transport of MDMA is not mediated by P-glycoprotein: a comparison with MDCK and Caco-2 monolayers. Biopharm. Drug Dispos. 27 (2006) 219-227
10. Seidel S., Singer E.A., Just H., Farhan H., Scholze P., Kudlacek O., Holy M., Koppatz K., Krivanek P., Freissmuth M., and Sitte H.H. Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol. Pharmacol. 67 (2005) 140-151
11. Pifl C., Nagy G., Berenyi S., Kattinger A., Reither H., and Antus S. Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters. J. Pharmacol. Exp. Ther. 314 (2005) 346-354
12. Kiyanvash N.K., Weiss J., Haefeli W.E., and Mikus G. P-glycoprotein modulation by the designer drugs methylendioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine. Addict. Biol. 8 (2003) 413-418
13. Mann H., Ladenheim B., Hirata H., Moran T.H., and Cadet J.L. Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice. Brain Res. 769 (1997) 340-346
14. Hidalgo I.J., Raub T.J., and Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 (1989) 736-749
15. Hilgers A.R., Conradi R.A., and Burton P.S. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 7 (1990) 902-910
16. Hidalgo I.J., and Borchardt R.T. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochim. Biophys. Acta 1028 (1990) 25-30
17. Bissonnette P., Gagne H., Coady M.J., Benabdallah K., Lapointe J.Y., and Berteloot A. Kinetic separation and characterization of three sugar transport modes in Caco-2 cells. Am. J. Physiol. 270 (1996) G833-G843
18. Mohrmann I., Mohrmann M., Biber J., and Murer H. Sodium-dependent transport of Pi by an established intestinal epithelial cell line (CaCo-2). Am. J. Physiol. 250 (1986) G323-G330
19. Hidalgo I.J., and Borchardt R.T. Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim. Biophys. Acta 1035 (1990) 97-103
20. + co-transport system in the Caco-2 human colon carcinoma cell line. Biochem. J. 299 Pt 1 (1994) 253-260
21. Daniel H., Fett C., and Kratz A. Demonstration and modification of intervillous pH profiles in rat small intestine in vitro. Am. J. Physiol. 257 (1989) G489-G495
22. Inoue T., and Suzuki S. Studies on metabolism of methamphetamine analogs 6. Analysis of dimethylamphetamine and its metabolites. Rep. Natl. Res. Inst. Police Sci. 39 (1986) 228-234
23. Tanaka K., Inoue T., and Ohki H. Analysis of 3,4-methylenedioxymethamphetamine and its metabolites. Rep. Natl. Res. Inst. Police Sci. 41 (1988) 22-27
24. Kanamori T., Tanaka K., Togawa Y., and Inoue T. Analysis of 3,4-methylenedioxyamphetamine and its N-alkyl analogues. Rep. Natl. Res. Inst. Police Sci. 51 (1998) 32-41
25. Kuwayama K., Miyauchi S., Tateoka R., Abe H., and Kamo N. Fluorescein uptake by a monocarboxylic acid transporter in human intestinal Caco-2 cells. Biochem. Pharmacol. 63 (2002) 81-88
26. Wright S.H., and Wunz T.M. Transport of tetraethylammonium by rabbit renal brush-border and basolateral membrane vesicles. Am. J. Physiol. 253 (1987) F1040-F1050
27. +/peptide cotransport systems in intestine (PEPT 1) and kidney (PEPT 2). Biochim. Biophys. Acta 1324 (1997) 251-262
28. Fujisawa Y., Tateoka R., Nara T., Kamo N., Taira T., and Miyauchi S. The extracellular pH dependency of transport activity by human oligopeptide transporter 1 (hPEPT1) expressed stably in Chinese hamster ovary (CHO) cells: a reason for the bell-shaped activity versus pH. Biol. Pharm. Bull. 29 (2006) 997-1005
29. Mizuuchi H., Katsura T., Ashida K., Hashimoto Y., and Inui K. Diphenhydramine transport by pH-dependent tertiary amine transport system in Caco-2 cells. Am. J. Physiol.: Gasterointest. Liver Physiol. 278 (2000) G563-G569
30. Thomas J.A. Intracellularly trapped pH indicators. Soc. Gen. Physiol. Ser. 40 (1986) 311-325
31. Katsura T., Mizuuchi H., Hashimoto Y., and Inui K. Transport of procainamide via H(+)/tertiary amine antiport system in rabbit intestinal brush-border membrane. Am. J. Physiol. Gasterointest. Liver Physiol. 279 (2000) G799-G805
32. Jonker J.W., and Schinkel A.H. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J. Pharmacol. Exp. Ther. 308 (2004) 2-9
33. Kim M.K., and Shim C.K. The transport of organic cations in the small intestine: current knowledge and emerging concepts. Arch. Pharm. Res. 29 (2006) 605-616
34. Miyamoto Y., Ganapathy V., and Leibach F.H. Transport of guanidine in rabbit intestinal brush-border membrane vesicles. Am. J. Physiol. 255 (1988) G85-G92
35. Raub T.J. P-glycoprotein recognition of substrates and circumvention through rational drug design. Mol. Pharmacol. 3 (2006) 3-25
36. Omote H., Hiasa M., Matsumoto T., Otsuka M., and Moriyama Y. The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol. Sci. 27 (2006) 587-593
37. +/organic cation antiporter MATE1. Pharm. Res. 23 (2006) 1696-1701
38. + antiporter in the kidney. Drug Metab. Dispos. 34 (2006) 1868-1874
39. +, sugar, and water transport across the intestine. Ann. N.Y. Acad. Sci. 915 (2000) 54-66
40. Ganapathy V., Ganapathy M.E., and Leibach F.H. Intestinal transport of peptides and amino acids (2001), Academic Press, New York 379-419
41. Chan L.M., Lowes S., and Hirst B.H. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 21 (2004) 25-51
42. Fischer W., Metzner L., Hoffmann K., Neubert R.H., and Brandsch M. Substrate specificity and mechanism of the intestinal clonidine uptake by Caco-2 cells. Pharm. Res. 23 (2006) 131-137
43. Torre R., Farre M., Navarro M., Pacifici R., Zuccaro P., and Pichini S. Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin. Pharmacokinet. 43 (2004) 157-185
44. Hidalgo I.J., Hillgren K.M., Grass G.M., and Borchardt R.T. Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus. Pharm. Res. 8 (1991) 222-227
45. Kottra G., Stamfort A., and Daniel H. PEPT1 as a paradigm for membrane carriers that mediate electrogenic bidirectional transport of anionic, cationic, and neutral substrates. J. Biol. Chem. 277 (2002) 32683-32691
46. + and substrate transport by the proton-dependent amino acid symporter PAT1. Biochem. J. 386 (2005) 607-616
47. Fujisawa Y., Kitagawa T., Miyake M., Nara T., Kamo N., and Miyauchi S. Measurement of electric current evoked by substrate transport via bi-directional H(+)/oligopeptide transporter over-expressed in HeLa cells: electrogenic efflux and existence of a newly observed channel-like state. Arch. Biochem. Biophys. 445 (2006) 166-173